JOST Werke (JST) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Q2 2024 sales reached €298.2 million, with €21 million from M&A, and adjusted EBIT at €33.8 million, maintaining an 11.3% margin despite softer markets.
Free cash flow for H1 2024 was €60.6 million, up 80.2% year-over-year, with leverage below 1x after a €22 million dividend payment.
Strategic investment of €15 million for a 10% stake in Trailer Dynamics to accelerate eTrailer technology and decarbonization efforts.
ROCE reached 19.7% and cash conversion rate was 1.3 in H1 2024, reflecting strong shareholder value.
2024 outlook confirmed, leveraging current market conditions to strengthen positioning and resilience.
Financial highlights
Q2 2024 sales: €298.2 million (-9.8% YoY); H1 2024: €596.7 million (-11.2% YoY); adjusted EBIT margin held at 11.3% in Q2 and 11.5% in H1.
Adjusted EPS for H1 2024 was €3.07; reported EPS was €2.31, down from €3.01 in H1 2023.
Free cash flow in H1 2024: €60.6 million; cash conversion rate: 1.3.
Net debt reduced to €168.1 million; leverage stable at 0.99x.
Equity ratio at 38.9% as of June 30, 2024.
Outlook and guidance
2024 sales and adjusted EBIT expected to decline single digits year-over-year, with EBIT margin in the upper half of the 10.0%-11.5% corridor.
CapEx to remain between 2.5%-2.9% of sales; working capital below 19% of sales.
Market demand in Europe and North America expected to contract, while Asia-Pacific-Africa remains stable or grows slightly.
Investments (excl. acquisitions) to focus on Brazil and APA.
Net working capital to revenue expected below 19%; leverage ratio to improve further, below 1.0x.
Latest events from JOST Werke
- Profitability and cash flow remained strong despite sales declines, with key acquisitions advancing.JST
Q3 20248 Jul 2026 - Record Q1 2026 sales and margin gains, driven by Hyva synergies and organic growth.JST
Q1 202613 May 2026 - Sales up 44% and adjusted EBIT up 29% in 2025, with further gains targeted for 2026.JST
Q4 202529 Mar 2026 - Strong 2025 growth, digital innovation, and Hyva integration drive ambitious 2030 targets.JST
Investor presentation5 Mar 2026 - Acquisitions and expansion add €100m in sales and boost agricultural market reach.JST
Investor Update22 Jan 2026 - Targets €2B+ sales, €10 EPS, and 10–12% EBIT margin by 2030, driven by innovation and M&A.JST
CMD 202421 Jan 2026 - Acquisition targets EUR 23–28m synergies, expands global reach, and closes in Q4 2024.JST
M&A Announcement20 Jan 2026 - Hyva acquisition to drive 50–60% sales growth and margin expansion in 2025.JST
Q4 202417 Dec 2025 - Q2 2025 sales up 31% on Hyva deal, with 2025 outlook reaffirmed despite margin pressure.JST
Q2 202523 Nov 2025